Subscribe to RSS
DOI: 10.1055/s-0029-1214166
Adjunctive Therapies in the Treatment of Osteomyelitis
Publication History
Publication Date:
30 April 2009 (online)

ABSTRACT
The current management for chronic osteomyelitis centers on adequate antibiotic coverage and surgical debridement of nonviable tissue. The eradication of osteomyelitis, however, often involves a prolonged and frustrating course of management. Nonsurgical adjunctive modalities have not been widely used, mostly due to a lack of perceived efficacy, and have remained in a state of infancy. In this article, we will outline the rationale, current status, and evidence for several potential adjuncts to osteomyelitis management.
KEYWORDS
Osteomyelitis - adjunctive therapy - hyperbaric oxygen therapy - biofilm - growth factor
REFERENCES
- 1 Lew D P, Waldvogel F A. Osteomyelitis. Lancet. 2004; 364 369-379
- 2 Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg. 2004; 188(Suppl) 57-66
- 3 Tice A D, Hoaglund P A, Shoultz D A. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med. 2003; 114 723-728
- 4 Lipsky B A, Berendt A R, Deery H G et al.. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006; 117(7, Suppl) 212S-238S
- 5 Lavery L A, Armstrong D G, Wunderlich R P, Mohler M J, Wendel C S, Lipsky B A. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29 1288-1293
- 6 Chen C E, Shih S T, Fu T H, Wang J W, Wang C J. Hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis: a preliminary report. Chang Gung Med J. 2003; 26 114-121
- 7 Chen C E, Ko J Y, Fu T H, Wang C J. Results of chronic osteomyelitis of the femur treated with hyperbaric oxygen: a preliminary report. Chang Gung Med J. 2004; 27 91-97
- 8 Gill A L, Bell C NA. Hyperbaric oxygen: its uses, mechanisms of action, and outcomes. QJM. 2004; 97 385-395
- 9 Kawashima M, Tamura H, Nagayoshi I, Takao K, Yoshida K, Yamaguchi T. Hyperbaric oxygen therapy in orthopedic conditions. Undersea Hyperb Med. 2004; 31 155-162
- 10 Chen X, Kidder L S, Lew W D. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthop Res. 2002; 20 142-150
- 11 Chen X, Schmidt A H, Tsukayama D T, Bourgeault C A, Lew W D. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur. J Bone Joint Surg Am. 2006; 88 1510-1523
- 12 Ross J J. Angiogenic gene therapy as a potential therapeutic agent in chronic osteomyelitis. Med Hypotheses. 2006; 67 161-163
- 13 Southwood L L, Frisbie D D, Kawcak C E, Ghivizzani S C, Evans C H, McIlwraith C W. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res. 2004; 22 66-72
- 14 Costerton J W. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005; 437 7-11
- 15 Calhoun J H, Manring M M. Adult osteomyelitis. Infect Dis Clin North Am. 2005; 19 765-786
- 16 Vercillo M, Patzakis M J, Holtom P, Zalavras C G. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res. 2007; 461 40-43
- 17 Mader J T, Guckian J C, Glass D L, Reinarz J A. Therapy with hyperbaric oxygen for experimental osteomyelitis due to Staphylococcus aureus in rabbits. J Infect Dis. 1978; 138 312-318
- 18 Mader J T, Brown G L, Guckian J C, Wells C H, Reinarz J A. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis. 1980; 142 915-922
- 19 Mandell G L. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun. 1974; 9 337-341
- 20 Barth E, Sullivan T, Berg E. Animal model for evaluating bone repair with and without adjunctive hyperbaric oxygen therapy (HBO): comparing dose schedules. J Invest Surg. 1990; 3 387-392
- 21 Hunt T K, Pai M P. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet. 1972; 135 561-567
- 22 Knighton D R, Silver I A, Hunt T K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981; 90 262-270
- 23 Park M K, Myers R A, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis. 1992; 14 720-740
- 24 Verklin Jr R M, Mandell G L. Alteration of effectiveness of antibiotics by anaerobiosis. J Lab Clin Med. 1977; 89 65-71
- 25 Bennett M H, Stanford R, Turner R. Hyperbaric oxygen therapy for promoting fracture healing and treating fracture non-union. Cochrane Database Syst Rev. 2005; (1) CD004712
- 26 Wang C, Schwaitzberg S, Berliner E, Zarin D A, Lau J. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg. 2003; 138 272-279
- 27 Davis J C, Heckman J D, DeLee J C, Buckwold F J. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg Am. 1986; 68 1210-1217
- 28 Esterhai Jr J L, Pisarello J, Brighton C T, Heppenstall R B, Gellman H, Goldstein G. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis. J Trauma. 1987; 27 763-768
- 29 Centers for Medicare and Medicaid Services .Medicare National Coverage Determinations Manual. 2007 Internet-only manual # 100-03 http://www.cms.hhs.gov/manuals/10m
- 30 Lentrodt S, Lentrodt J, Kubler N, Modder U. Hyperbaric oxygen for adjuvant therapy for chronically recurrent mandibular osteomyelitis in childhood and adolescence. J Oral Maxillofac Surg. 2007; 65 186-191
- 31 Esterhai Jr J L, Pisarello J, Brighton C T, Heppenstall R B, Gellman H, Goldstein G. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis. J Trauma. 1987; 27 763-768
- 32 Southwood L L, Frisbie D D, Kawcak C E, Ghivizzani S C, Evans C H, McIlwraith C W. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res. 2004; 22 66-72
- 33 Costerton J W, Stewart P S, Greenberg E P. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284 1318-1322
- 34 Gristina A G, Oga M, Webb L X, Hobgood C D. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science. 1985; 228 990-993
- 35 Mayberry-Carson K J, Tober-Meyer B, Smith J K, Lambe Jr D W, Costerton J W. Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus. Infect Immun. 1984; 43 825-833
- 36 Monzon M, Garcia-Alvarez F, Lacleriga A et al.. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment. J Orthop Res. 2001; 19 820-826
- 37 Dell'Acqua G, Giacometti A, Cirioni O et al.. Suppression of drug-resistant Staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis. 2004; 190 318-320
- 38 Cirioni O, Giacometti A, Ghiselli R et al.. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation. 2003; 108 767-771
- 39 Balaban N, Collins L V, Cullor J S et al.. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides. 2000; 21 1301-1311
- 40 Nelson F R, Brighton C T, Ryaby J et al.. Use of physical forces in bone healing. J Am Acad Orthop Surg. 2003; 11 344-354
- 41 Guerkov H H, Lohmann C H, Liu Y et al.. Pulsed electromagnetic fields increase growth factor release by nonunion cells. Clin Orthop Relat Res. 2001; 384 265-279
- 42 Nagai M, Ota M. Pulsating electromagnetic field stimulates mRNA expression of bone morphogenetic protein-2 and -4. J Dent Res. 1994; 73 1601-1605
- 43 Rubin C, Bolander M, Ryaby J P, Hadjiargyrou M. The use of low-intensity ultrasound to accelerate the healing of fractures. J Bone Joint Surg Am. 2001; 83 259-270
- 44 Parvizi J, Wu C C, Lewallen D G, Greenleaf J F, Bolander M E. Low-intensity ultrasound stimulates proteoglycan synthesis in rat chondrocytes by increasing aggrecan gene expression. J Orthop Res. 1999; 17 488-494
- 45 Yang K H, Parvizi J, Wang S J et al.. Exposure to low-intensity ultrasound increases aggrecan gene expression in a rat femur fracture model. J Orthop Res. 1996; 14 802-809
- 46 Rawool N M, Goldberg B B, Forsberg F, Winder A A, Hume E. Power Doppler assessment of vascular changes during fracture treatment with low-intensity ultrasound. J Ultrasound Med. 2003; 22 145-153
- 47 Ehrlich G D, Stoodley P, Kathju S et al.. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res. 2005; 437 59-66
- 48 McLeod B R, Fortun S, Costerton J W, Stewart P S. Enhanced bacterial biofilm control using electromagnetic fields in combination with antibiotics. Methods Enzymol. 1999; 310 656-670
- 49 Eppley B L, Pietrzak W S, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg. 2006; 118 147e-159e
- 50 Liu Y, Kalen A, Risto O, Wahlstrom O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen. 2002; 10 336-340
- 51 Marx R E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004; 62 489-496
Robert D GalianoM.D.
Assistant Professor of Surgery, Division of Plastic and Reconstructive Surgery, Department of Surgery
Northwestern University Feinberg School of Medicine, Galter Pavilion 19-250, 675 N. St. Clair Street, Chicago, IL 60611
Email: rgaliano@nmh.org